Moody's Investors Service affirmed the long-term underlying "Aa3" ratings of Yale New Haven (Conn.) Health, affecting $715 million of rated debt.
The rating reflects Moody's expectation that the system will continue to enjoy its leading market position in Connecticut along with the strong brand recognition associated with Yale University. Yale New Haven Health not only has a broad reach for tertiary and quaternary patients throughout the state but has been expanding its presence through consolidation.
The rating outlook is stable.